To address if inactivation of ARID1A in CCA was associated with alterations of PI3K/AKT signaling, the mutations of ARID1A and genes in RAS/PI3K/AKT pathway were assessed using cBioPortal. This evidence concerns the gene AKT1 and cholangiocarcinoma.